Camp4 Therapeutics (CAMP) Other Non Operating Income (2024 - 2026)

Camp4 Therapeutics (CAMP) reported Other Non Operating Income of -$6.2 million for Q1 2026, up 77.92% sequentially from -$28.0 million in Q4 2025.

Camp4 Therapeutics (CAMP) Other Non Operating Income (2024 - 2026) Analysis & Trends

Camp4 Therapeutics (CAMP) has 3 years of Other Non Operating Income data on file, last reported at -$6.2 million in Q1 2026.

For the quarter ending Q1 2026, Other Non Operating Income changed N/A year-over-year to -$6.2 million; the trailing twelve-month figure through Mar 2026 stood at -$36.0 million (down 124141.38% YoY), and the FY2025 full-year result was -$29.8 million, changed N/A from the prior year.
Other Non Operating Income grew to -$6.2 million in Q1 2026, from -$28.0 million in the prior quarter.
In the past five years, Other Non Operating Income ranged from a high of $178000.0 in Q4 2024 to a low of -$28.0 million in Q4 2025.
A 3-year average of -$4.5 million and a median of -$103500.0 in 2024 frame the typical range for Other Non Operating Income.
Peak annual rise in Other Non Operating Income reached 91.72% in 2025, while the deepest fall reached 15847.19% in 2025.
Tracing CAMP's Other Non Operating Income over 3 years: stood at $178000.0 in 2024, then sank by 15847.19% to -$28.0 million in 2025, then surged by 77.92% to -$6.2 million in 2026.
Business Quant data shows CAMP's Other Non Operating Income at -$6.2 million in Q1 2026, -$28.0 million in Q4 2025, and -$1.8 million in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Camp4 Therapeutics	174.35 Mn	174.35 Mn	-

Download Data